US 11833211
Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2
granted A61KA61K38/05A61K38/10
Quick answer
US patent 11833211 (Methods of suppression and treatment of disease comprising administering bicycle peptide ligands specific for EphA2) held by BicycleTx Limited expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BicycleTx Limited
- Grant date
- Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/05, A61K38/10, A61K47/62, A61K47/64